Announcements

Fresh capital to accelerate AI-powered digital transformation in healthca

Athelas will be at AAOE 2026 in Louisville, April 20 to 22, and one lucky visitor will get a chance to win a Napa Valley experience for two.

3-Minute FDA-Cleared Blood Diagnostics Powered by Cutting Edge Hardware and ML

Athelas products will help Raleigh Orthopaedic streamline clinical and administrative tasks, giving clinicians more time to spend on patient care

Read Athelas's announcement of the Air EHR rollout across Lattimore Physical Therapy's 35-location network.

Explore the redesigned Athelas Claims Page, including filters, custom views and tools for reviewing, editing and submitting claims.

Read the introduction to Commure Strongline Pro and its healthcare staff-safety offering.

See the Home Exercise Plan Library update, including changes to exercise visuals and consistency.

Commure and Athelas sign to acquire AUGX.

Athelas/Commure, a leading healthcare technology company, acquihires RoBhat Labs, and brings on founder Ash Bhat to work on special projects.

The new fundraising round brings Athelas's valuation to $1.5 billion.

Integrated technology and innovative health-at-home solutions are transforming the healthcare experience for patients and providers alike.

We are excited to share that Athelas, powered by Commure, has raised $200 million in growth funding from General Catalyst’s Customer Value Fund (CVF).

The ranking brings Athelas in the same list of iconic startups such as Airbnb, Brex, and Stripe.

Read highlights from the Athelas quarterly Summit, including partner collaboration and demonstrations of healthcare AI workflows.

Read the Athelas Air launch announcement for an EHR combining charting, billing and ambient AI workflows.

Read Athelas's February 2026 announcement about FDA clearance of Athelas Home for point-of-care use.

Read the October 2024 announcement about Athelas-Commure and HCA Healthcare's plans for an ambient AI platform.

Read the announcement of the Athelas and Commure merger and the combined company's healthcare technology plans.

‘Athelas Home’ cleared by the FDA and granted CLIA-waived status: a landmark FDA clearance for oncology, severe mental illness, and general at-home care.

Read how a practice responded to the Change Healthcare cyberattack with support from Athelas's launch team.

Check out the top Y Combinator companies shaping the future of healthcare.